share_log

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

生物親和技術從行使認股權證中獲得額外 770 萬美元
Benzinga Real-time News ·  2022/09/28 20:16

$bioAffinity Technologies (BIAF.US)$ today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the Company's September 6, 2022, public offering of securities.

$bioAffinity Technologies (BIAF.US)$今天宣佈，公司於 2022 年 9 月 6 日公開發售證券行使可買賣及不可交易認股權證所得的額外收益總額約 770 萬美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論